Efficacy and Safety of R-HAD Alone or in Combination With Bortezomib in Patients With Relapsed or Refractory MCL
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Mantle Cell Lymphoma
Related studies linked through entity extraction aliases.
Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)
- Status
- UNKNOWN
- Phase
- PHASE1
Ofatumumab With or Without Bendamustine for Patients With Mantle Cell Lymphoma Ineligible for Autologous Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- Vincristine
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Imexon for Relapsed Follicular and Aggressive Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
AMG 319 Lymphoid Malignancy FIH
- Status
- COMPLETED
- Phase
- PHASE1
Nonmyeloablative Allogeneic Transplant
- Status
- COMPLETED
- Phase
- NA
A Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Safety and Efficacy of PCI-32765 in Participants With Relapsed/Refractory Mantle Cell Lymphoma (MCL)
- Status
- COMPLETED
- Phase
- PHASE2
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE3
A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Trial of PD 0332991 Plus Bortezomib in Patients With Relapsed Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2